US Material Events SEC 8-K Filings — April 15, 2026

15-04-2026

On April 13, 2026, the Compensation Committee of Lionsgate Studios Corp. approved amendments to CEO Jon Feltheimer's employment agreement, extending the term to July 31, 2031, and granting him options to purchase 4,500,000 common shares at $11.07 per share and 666,667 RSUs in three performance-based tranches tied to stock price goals of $17.50, $20.00, and $22.50 over 20 consecutive trading days within five years. The amended agreement maintains his $1.5M annual base salary, $7.5M target bonus (up to 200% maximum), and provides for $10M target annual equity grants for fiscal years 2026 through 2029. No declines or flat performance metrics reported in this compensation-focused filing.

• ·Awards vest only if stock price goals achieved within 5 years and service through 5th anniversary (or qualifying termination)
• ·In change of control, achieved tranches subject only to time-vesting; others terminate
• ·Annual grants include time-vesting RSUs, options/SARs, and performance RSUs, vesting in 3 equal annual installments
• ·Performance-based annual RSUs contingent on 12-month metrics; all grants settle in shares, cash, or mix
• ·Severance upon without cause/good reason: PV of base salary to term end, target bonus, benefits continuation; full equity acceleration
• ·Retirement after 6 months notice: continued vesting of certain equity, 5-year exercise period

15-04-2026

On April 9, 2026, Hallador Energy Company's Board approved the 2026 Executive Officer Plan, replacing the expired 2024 plan, with base salary increases for named executives: Brent Bilsland (CEO) to $800,000 (+18.5% from $675,000), Todd Telesz (CFO) to $525,000 (+5% from $500,000), and Heath Lovell (COO) to $500,000 (+11.1% from $450,000). The plan includes target performance bonuses of $500,000, $200,000, and $300,000 respectively, tied to safety, Adjusted EBITDA ($68.0M target), discretionary, and strategic goals, plus one-time RSU grants valued at approximately $1,200,000, $275,000, and $400,000. New severance and change-in-control retention provisions were also established, including lump sum payments up to $2,400,000 for Bilsland.

• ·RSUs vest ratably on March 31, 2027, 2028, and 2029; accelerate fully on change in control.
• ·Performance bonuses paid in March 2027 post-audit, subject to continued service through Dec 31, 2026.
• ·Safety goals based on 2022-2025 national averages for Sunrise Coal and Hallador Power.
• ·Severance equals 12 months base salary (effective April 1, 2026) plus prior year bonus.
• ·Change-in-control retention requires 3-month post-closing work agreement with acquirer.

15-04-2026

On April 14, 2026, Mike Krieger resigned from the Board of Directors of Figma, Inc. effective immediately, with no disagreements on operations, policies, or practices. The Board expressed thanks for his service and contributions. No other changes or impacts were disclosed.

• ·Filing submitted on April 15, 2026, reporting event of April 14, 2026.
• ·Figma, Inc. is an emerging growth company.

15-04-2026

Spire Inc. entered into a definitive agreement to sell its natural gas storage assets (Spire Storage in Wyoming and Oklahoma) to I Squared Capital for $650 million ($600 million cash at closing plus $50 million deferred payment in FY2027), sharpening focus on regulated utility businesses and improving risk profile while funding the recent Piedmont Natural Gas Tennessee acquisition. The transaction supports system reliability under new ownership and is expected to close in the second half of FY2026, subject to customary conditions and HSR antitrust review. Spire affirmed FY2026 adjusted EPS guidance of $5.25–$5.45 and FY2027 guidance of $5.40–$5.60, reaffirming 5-7% long-term EPS growth from the original FY2027 midpoint of $5.75.

• ·Spire Storage West located in southwestern Wyoming, serves western U.S.; Salt Plains in north central Oklahoma, connected to Southern Star Pipeline and Oklahoma Gas Transmission, serves midcontinent and midwestern U.S.
• ·Transaction subject to customary closing conditions and HSR antitrust waiting period expiration/termination.
• ·Sale of Spire Marketing expected to close in Q3 FY2026; both sales subject to regulatory approvals.
• ·Greenhill (Mizuho affiliate) as Spire's exclusive financial advisor; Vinson & Elkins as Spire legal counsel; Kirkland & Ellis as I Squared legal advisor.
• ·Revised 2026 guidance to be provided on Q2 FY2026 earnings call in May 2026.
• ·Piedmont Natural Gas Tennessee acquisition closed March 31, 2026.

15-04-2026

Structure Therapeutics Inc. (NASDAQ: GPCR) appointed Matthew Lang, J.D. as Chief Operating Officer and General Counsel, leveraging his over 15 years of executive experience from Metsera, Lyell Immunopharma, Myovant Sciences, and Gilead Sciences. CEO Raymond Stevens emphasized Lang's expertise in growth, strategic transactions, and commercialization, critical for advancing aleniglipron into Phase 3 trials. The appointment strengthens the leadership team amid a competitive obesity pipeline development.

• ·Announcement date: April 14, 2026
• ·Mr. Lang managed Myovant’s European operations in Basel, Switzerland
• ·Company pipeline targets GPCR for obesity and metabolic diseases via structure-based drug discovery platform

15-04-2026

Strawberry Fields REIT, Inc. disclosed various risk factors in an 8-K filing, highlighting heavy concentration risks with 86.8% of annualized base rent from 15 master leases affiliated with executives Moishe Gubin and Michael Blisko, and 97.7% derived from skilled nursing facilities. The company also faces substantial indebtedness of $752.1 million as of December 31, 2025, along with vulnerabilities from related-party leases not negotiated at arm's length, potential tenant defaults, labor shortages, inflation, and dependence on key personnel. These factors could materially adversely affect operations, financial condition, and distributions to stockholders.

• ·Leases with related parties not negotiated on arm’s-length basis and subject to conflicts of interest policies requiring audit committee approval.
• ·Tenants under master leases are affiliates, increasing risk of widespread defaults from single adverse events like regulatory exclusions from Medicare/Medicaid.
• ·Portfolio lacks diversification, with tenant base limited to skilled nursing operators dependent on government reimbursements.

15-04-2026

World Acceptance Corporation (NASDAQ: WRLD) appointed Janet Matricciani as interim President and CEO effective April 13, 2026, following the resignation of R. Chad Prashad as President, CEO, and board member to pursue other opportunities. The board, chaired by Ken Bramlett, Jr., praised Ms. Matricciani's prior CEO experience and initiated a search for a permanent replacement. No immediate financial impacts were disclosed.

• ·Founded in 1962 and headquartered in Greenville, South Carolina.
• ·Fiscal year ended March 31, 2025 (reference to latest 10-K).
• ·Website: www.loansbyworld.com.

15-04-2026

Luther C. Kissam, IV, a member of OGE Energy Corp.'s Board of Directors, informed the company on April 13, 2026, that he will not stand for re-election and will resign effective at the annual shareholder meeting on May 14, 2026, due to accepting a new CEO position at another company. There are no disagreements with the company's operations, policies, or practices. The Board size will reduce to eight directors, and proxy materials have been amended to remove him as a nominee.

• ·Mr. Kissam has served more than five years on the Board and various committees.
• ·Previously voted proxies remain valid except with respect to Mr. Kissam.
• ·Annual shareholder meeting scheduled for May 14, 2026.

15-04-2026

Leidos Holdings, Inc. (NYSE: LDOS) and investment firm Altaris have formed a U.S.-based joint venture by combining Leidos' Security Enterprise Solutions (SES) business, contributing approximately 1,500 employees and $625 million in projected 2026 revenue, with Altaris-owned Analogic to enhance global security screening capabilities for airports, borders, and critical infrastructure. The JV will operate under the Analogic brand with Leidos retaining significant minority ownership, aiming to drive innovation in AI-native and 3D imaging solutions while allowing Leidos to focus on core growth areas in its NorthStar 2030 strategy. The transaction is expected to close in the second half of 2026, subject to regulatory approvals and customary conditions.

• ·Leidos headquartered in Reston, Virginia; Analogic in Salem, NH; Altaris in New York City.
• ·Advisors: Leidos - PJT Partners (financial), Fried Frank Harris Shriver & Jacobson LLP and DLA Piper (legal), KPMG (accounting); Analogic - Kirkland & Ellis LLP and Hinckley Allen & Snyder LLP (legal), Ernst & Young LLP (accounting).

15-04-2026

Pantages Capital Acquisition Corporation filed an 8-K disclosing Amendment No. 1 to its Business Combination Agreement originally dated November 18, 2025, executed on April 14, 2026. The sole change amends and restates Section 8.1(h) to be intentionally omitted, with all other terms of the agreement remaining in full force and effect. The amendment involves parties including MacMines Austasia Pty Ltd (Company), Horizon Mining Limited (Pubco), and others, signed by key representatives.

• ·Original Business Combination Agreement dated November 18, 2025.
• ·Amendment filed as EX-2.1 under Items 1.01 and 9.01 of 8-K on April 15, 2026.

15-04-2026

Allbirds, Inc. entered into Support Agreements on April 8, 2026, with stockholders holding approximately 71% of voting power (as of February 28, 2026) to vote in favor of the previously announced Asset Sale to Allbirds IP LLC, affiliated with American Exchange Group, as recommended by the Board at an upcoming Special Meeting. The supporting stockholders include Maveron (a >5% holder of Class B common stock) and board members Joey Zwillinger, Tim Brown, and Dick Boyce. The company intends to file a Proxy Statement with the SEC and notes risks to consummation, including stockholder approval and closing conditions.

• ·Asset Purchase Agreement originally entered on March 29, 2026
• ·Proxy Statement to be filed with SEC in connection with Special Meeting
• ·8-K filed on April 15, 2026; event date April 8, 2026

15-04-2026

Regis Corporation (Nasdaq: RGS) announced the appointment of William 'Bill' Charters as an independent director, effective April 24, 2026, adding expertise in capital markets, restructurings, and franchise models from one of its largest individual shareholders. Susan Lintonsmith, President and CEO, highlighted his value in executing the transformation strategy and enhancing shareholder value. The Board now consists of seven directors, six independent.

• ·Mr. Charters is a CFA charterholder with experience at Botti Brown Asset Management (multi-billion-dollar hedge fund).
• ·Investor contacts: James Carbonara (646-755-7412) and Brett Maas (646-536-7331) at Hayden IR.

15-04-2026

Aspire Biopharma Holdings, Inc. entered into a non-binding letter of intent (LOI) on April 15, 2026, to acquire 100% of the Driver Controls Systems (DCS) business unit of Firefish Topco, LLC for an enterprise value of $30.0 million on a cash-free, debt-free basis, payable in cash at closing subject to customary adjustments. The LOI includes $3.5 million break-up fees, a 30-day exclusivity period with no-shop provisions, and plans to engage Lakewood & Company, LLC for post-acquisition management services. Completion remains subject to definitive agreements and conditions, with no new equity raise anticipated.

• ·LOI is non-binding except for exclusivity, confidentiality, expenses, and break-up fees post-disclosure.
• ·Purchase not subject to working capital adjustment if operated in ordinary course.
• ·Lakewood & Company principals have more than 100 years of automotive industry experience.

15-04-2026

Keen Vision Acquisition Corp., a blank check company, entered into a binding letter of intent (LOI) with Medera Inc. and its wholly-owned subsidiary Novoheart Group Limited to pursue a replacement merger agreement, following the termination of a prior merger agreement dated September 3, 2024. The LOI, amended on April 14, 2026, extends the deadline for executing the Replacement Merger Agreement from April 10 to April 30, 2026. No financial terms were disclosed in the filing.

• ·Prior Merger Agreement dated September 3, 2024 terminated concurrently with LOI execution via mutual release.
• ·LOI amendment dated April 14, 2026 extends Replacement Merger Agreement deadline to April 30, 2026.
• ·Securities traded on Nasdaq: KVACU (Units), KVAC (Ordinary Shares), KVACW (Warrants).

15-04-2026

Stereotaxis, Inc. filed an 8-K on April 15, 2026, disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No specific financial metrics or period-over-period comparisons are detailed in the filing metadata. The filing size is 3 MB, indicating potential exhibits or press releases attached.

• ·CIK: 0001289340
• ·SIC: 3845 (Electromedical & Electrotherapeutic Apparatus)
• ·Business Address: 710 N Tucker Blvd Ste 110, St. Louis, MO 63101
• ·Fiscal Year End: December 31

15-04-2026

Graham Corporation (NYSE: GHM) announced a $50 million investment from accounts advised by T. Rowe Price Investment Management, Inc., involving the sale of 599,808 shares (5% of common stock) at $83.36 per share, based on the 20-day average closing price as of April 13, 2026. The transaction is expected to close on April 16, 2026, subject to customary conditions, with proceeds intended for debt repayment to strengthen the balance sheet and funding organic and inorganic growth opportunities. CEO Matthew J. Malone highlighted the investment as validation of the company's platform and support for long-term shareholder value.

• ·Transaction expected to close on April 16, 2026, subject to customary closing conditions
• ·Stock purchase agreement includes registration statement to be filed with SEC within 30 days
• ·Proceeds to enhance financial flexibility for debt repayment and growth investments

15-04-2026

Prelude Therapeutics Incorporated (Nasdaq: PRLD) announced the appointment of Dr. Charles Morris, M.D. as Chief Medical Officer effective April 20, 2026, to lead the advancement of its two lead programs targeting myeloproliferative neoplasms and ER+ breast cancer into clinical development in 2026. Dr. Morris brings over 30 years of oncology drug development experience, including prior CMO roles at Lava Therapeutics, Celyad Oncology, Radius Health, ImmunoGen, and Allos Therapeutics, and contributions to approvals of ONSERDU, ELAHERE, and Faslodex. CEO Kris Vaddi highlighted Dr. Morris's expertise as instrumental for executing these programs with rigor.

• ·Dr. Morris holds a medical degree and Bachelor of Medical Science in Clinical Pharmacology and Therapeutics from Sheffield University Medical School and is a Member of the Royal College of Physicians of London.
• ·Investor contact: Robert A. Doody, Jr. at 484.639.7235 or rdoody@preludetx.com

15-04-2026

Mount Logan Capital Inc. appointed Jordan Mangum, age 33, as Executive Vice President and Chief Operating Officer effective April 13, 2026, following a board decision on April 9, 2026. Mr. Mangum will continue his role as a Director on the credit team at BC Partners Advisors L.P. (BCPA), with services provided under the Staffing and Resource Agreement (dated November 18, 2025) and Servicing Agreement (dated March 17, 2023). Potential conflicts of interest exist due to the Company's reliance on BCPA for asset management and BCPA's minority equity interest via an affiliate.

• ·Mr. Mangum joined BCPA in March 2022, worked at Onex Private Credit division from March 2020 to March 2022, and held roles at Bank of America Merrill Lynch Global Corporate and Investment Banking from February 2015 to March 2020.
• ·Mr. Mangum holds a B.S. in Finance and a B.S. in Accounting from the Pamplin College of Business at Virginia Tech.
• ·No family relationships with current directors or officers; no new compensatory arrangements with the Company.

15-04-2026

On April 13, 2026, Trans-Lux Corporation accepted the resignation of John Hammock as Interim Chief Executive Officer, with no disagreements on operations, policies, or practices. The Board appointed Yantao (Tony) Yu, age 50 and previously a director since July 30, 2019, and COO since August 1, 2021, as the new CEO. Mr. Yu will receive $26,000 per year from the Company while also compensated by Unilumin, its largest stockholder.

• ·Mr. Yu has served as CFO of Unilumin USA since September 2018.
• ·Mr. Yu holds an Executive MBA from the University of Minnesota and certifications including CPA, CGA, CMA, and FCCA.
• ·Mr. Yu is not a party to any Item 404(a) transactions except his employment with the Company; no arrangements with others for his selection.
• ·Filing signed by Todd Dupee on April 15, 2026.

15-04-2026

Wave Life Sciences Ltd. (Nasdaq: WVE) announced that its board of directors unanimously approved a plan to redomicile the parent company from Singapore to the United States as a new Delaware corporation, Wave Life Sciences, Inc., via a one-for-one exchange of ordinary shares for common stock. The move aims to streamline organizational structure, enhance administrative efficiencies, and reduce dual financial reporting and compliance costs, with the company continuing to trade on Nasdaq under 'WVE' and report under U.S. GAAP. Subject to shareholder approval and Singapore High Court sanction, the redomiciliation is expected to take effect in mid-2026 and be tax-free for U.S. shareholders.

• ·Preliminary proxy materials filed with SEC on April 15, 2026, in preparation for shareholder meeting.
• ·Proxy statement for 2025 Annual Meeting of Shareholders filed with SEC on June 23, 2025.
• ·Headquartered in Cambridge, MA.

15-04-2026

On April 14, 2026, Launchpad Cadenza Acquisition Corp I appointed Sheldon Sussman, age 70, as a new member of the Board of Directors effective immediately, and as chair of the Audit Committee, replacing Jonathan Bier who remains a member. Sussman brings extensive experience in global financial markets, including roles at Napier Park Global Capital, Cohen Circle, and building a $25 billion asset management platform at Rabobank International. No family relationships, material transactions, or compensatory arrangements beyond standard agreements were disclosed.

• ·Appointment effective April 14, 2026; filing date April 15, 2026.
• ·Sussman signed joinder to letter agreement dated December 17, 2025 (waiver of redemption rights, vote in favor of initial business combination).
• ·Sussman signed joinder to registration rights agreement dated December 17, 2025.
• ·Standard director indemnity agreement (form filed as Exhibit 10.6 to S-1 on November 10, 2025).

15-04-2026

LQR House Inc. entered into a Share Purchase Agreement on April 11, 2026, to acquire all 10,000 ordinary shares of Fusion Five Continents Securities Limited, a New Zealand brokerage enabling stablecoin deposits for trading Hong Kong and U.S. equities, for a total of $126,880,000 payable in USDT, with an initial closing of 24% (2,400 shares) for $28,080,000 no later than April 24, 2026, and the remaining 76% (7,600 shares) for $98,800,000 after regulatory approvals. In connection with the acquisition, the Board appointed Yuting “Tina” Luo (to Audit and Nominating Committees) and Hoi Ho George Wong (to Compensation Committee) as independent directors on April 10, 2026, each entitled to $48,000 annual cash fees. No financial performance metrics or declines were reported.

• ·Initial closing required no later than April 24, 2026.
• ·Second closing(s) after 10 business days following satisfaction of conditions including regulatory approvals.
• ·Payments to be made in Tether (USDT) to seller-designated wallet.
• ·New directors appointed April 10, 2026, with standard indemnification agreements and $48,000 annual fees payable monthly.

15-04-2026

On April 10, 2026, Michael Niggli notified ESS Tech, Inc. that he is resigning from the Board of Directors, Audit Committee, and Nominating and Corporate Governance Committee, effective as of the 2026 annual meeting of stockholders on May 29, 2026. The resignation was not the result of any disagreement with the Company on matters relating to its operations, policies, or practices. The Company expressed gratitude for Mr. Niggli's leadership as Founding Chairman and his years of service.

• ·Resignation notified on April 10, 2026
• ·Annual meeting scheduled for May 29, 2026

15-04-2026

Eton Pharmaceuticals, Inc. entered into the Sixth Amendment to its Credit Agreement, originally dated November 13, 2019, with SWK Funding LLC as agent and sole lender, effective April 9, 2026. The amendment updates Annex I to confirm SWK Funding LLC's $40,000,000 term loan commitment at 100% pro rata share. Effectiveness is conditioned on the consummation of mergers under the October 9, 2025 Agreement and Plan of Merger involving Runway Growth Finance Corp. and SWK Holdings Corporation, with no changes to financial performance metrics disclosed.

• ·Amendment filed as 8-K on April 15, 2026, covering Items 1.01, 2.03, and 9.01
• ·Conditions precedent include payment of Agent’s and Runway’s outside counsel fees, true and correct representations/warranties, and no Default or Event of Default
• ·No waiver of any past, present, or future non-compliance under the Credit Agreement

15-04-2026

Harvard Apparatus Regenerative Technology, Inc. issued a $300,000 bridge note to Junli He on April 13, 2026, bearing 8% annual interest and maturing on the earlier of a capital raise of at least $5,000,000 or April 13, 2027. The note allows optional conversion into equity securities upon a qualified financing of at least $300,000 at the financing price. No period-over-period financial metrics are provided, but the issuance signals short-term liquidity needs ahead of larger fundraising.

• ·Prepayment allowed at any time without penalty or premium.
• ·Governed by laws of Massachusetts; parties waive jury trial.
• ·Events of default include Act of Bankruptcy, Sale of the Company, or failure to pay judgments over $100,000.

15-04-2026

On April 9, 2026, Trinity Industries Leasing Company (TILC), a wholly-owned subsidiary of Trinity Industries, Inc., entered into a Contribution Agreement, contributing its 42.56% membership interest in TRIP Rail Holdings LLC and 0.2% interest in Triumph Rail Holdings LLC to NP SPE Holdings LP in exchange for a 11.2% limited partnership interest in NP SPE. As a result, TILC no longer holds any direct ownership in TRIP Holdings or Triumph Holdings, and these entities will no longer be consolidated in Trinity's financial statements. The Contribution Agreement is filed as Exhibit 10.1.

• ·Filing date: April 15, 2026
• ·Date of earliest event reported: April 9, 2026

15-04-2026

Flowserve Corporation entered into a Third Amended and Restated Credit Agreement dated April 15, 2026, providing $1,450,000,000 in senior credit facilities, including a $1,000,000,000 revolving credit facility and an implied $450,000,000 term loan facility. Bank of America, N.A. serves as Administrative Agent, Swing Line Lender, and L/C Issuer, with other major banks as Co-Syndication Agents and Co-Documentation Agents. The agreement includes an Alternative Currency Sublimit of $350,000,000 within the revolving commitments.

15-04-2026

Federal Realty OP LP entered into a Third Amended and Restated Credit Agreement dated April 14, 2026, amending and restating its prior agreement from October 5, 2022, to provide an unsecured revolving credit facility of $1,400,000,000, including a $100,000,000 swingline subfacility and a $50,000,000 letter of credit subfacility. The agreement involves multiple lenders led by Wells Fargo Bank, National Association as Administrative Agent, with PNC Capital Markets LLC as Sustainability Structuring Agent. No performance metrics or changes from prior facility size are disclosed.

• ·Loan Number: 1004039
• ·Prior agreement dated October 5, 2022

15-04-2026

On April 9, 2026, Hyundai Capital America (Sponsor), Hyundai ABS Funding, LLC (Depositor), Hyundai Auto Receivables Trust 2022-A (Issuing Entity), Citibank, N.A. (Indenture Trustee), and U.S. Bank Trust National Association (Owner Trustee) entered into an Omnibus Distribution and Termination Agreement, with the consent of owners holding 100% of the outstanding certificates and all classes of notes. The agreement, attached as Exhibit 10.1, signals the wind-down of the trust. The 8-K was filed on April 15, 2026.

• ·Central Index Key Numbers: Hyundai Auto Receivables Trust 2022-A (0001913196), Hyundai ABS Funding, LLC (0001260125), Hyundai Capital America (0001541028)

15-04-2026

Saga Communications, Inc. announced that CEO Christopher S. Forgy has resumed all regular duties and responsibilities following a temporary medical leave of absence that began on February 13, 2026, due to recovery from open heart surgery. During his intermittent absence, Mr. Forgy remained available for consultation on significant matters, returned part-time initially, and led the company's 4th Quarter and Year-End 2025 conference call on March 12, 2026. The executive team, led by COO Wayne Leland and CFO Samuel D. Bush, ensured continuity of operations.

• ·Medical leave required an indefinite period of recovery from open heart surgery.
• ·Filing signed by Samuel D. Bush on April 15, 2026.

15-04-2026

U.S. Physical Therapy, Inc. entered into a Fourth Amended and Restated Credit Agreement on April 14, 2026, amending and restating the Third Amended and Restated Credit Agreement dated June 17, 2022, to provide a modified revolving credit facility and term loan facility. Bank of America, N.A. serves as Administrative Agent, Swingline Lender, and L/C Issuer, with other banks including Regions Capital Markets as Syndication Agent and Citizens Bank, N.A., JPMorgan Chase Bank, N.A., and U.S. Bank National Association as Co-Documentation Agents. The agreement constitutes an extension and renewal of prior indebtedness without extinguishment.

• ·CUSIP Numbers: Published 90355KAD9, Revolver 90355KAE7, Term Loan 90355KAF4.
• ·Applicable Rate grid has 5 pricing levels based on Consolidated Leverage Ratio from <1.25:1.0 (Level 1: Term SOFR/LC Fee 1.250%, Base Rate 0.250%, Commitment Fee 0.225%) to ≥3.25:1.0 (Level 5: 2.250%, 1.250%, 0.350%).
• ·SEC 8-K filed April 15, 2026, Items 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), 9.01 (Financial Statements and Exhibits).

15-04-2026

Ford Motor Co (CIK: 0000037996) filed an 8-K on April 15, 2026, under Items 5.02 (Director/Officer Departure/Election), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), indicating potential changes in directors or officers alongside other disclosures. The filing size is 2 MB, part of ongoing regulatory updates. No specific financial metrics, performance changes, or detailed personnel details are available in the provided filing index.

• ·Filing accession number: 0000037996-26-000081
• ·Subcategory: Director/Officer Departure/Election
• ·Mailing/Business Address: One American Rd, Dearborn, MI 48126
• ·Phone: 3133223000
• ·SIC: 3711 (Motor Vehicles & Passenger Car Bodies)
• ·Fiscal Year End: December 31

15-04-2026

On April 10, 2026, the Board of Directors of Viskase Holdings, Inc. appointed Michael Blecic as Chief Financial Officer, effective immediately, while he continues as Vice President, Chief Accounting Officer, and Treasurer of subsidiary Viskase Companies, LLC, with no additional compensation beyond standard merit eligibility. The service of interim CFO Mackenzie Stender, provided through Silverman Consulting, Inc., was terminated on the same date. Additionally, Joseph D. King was appointed Executive Vice President, retaining his roles as Senior Vice President, General Counsel, and Secretary, also without extra compensation.

• ·Michael Blecic, age 57, joined Viskase Companies in 1995 and has held various positions since.
• ·No arrangements or understandings with other persons for Blecic's selection; no family relationships with directors/officers; no material interests under Item 404(a) of Regulation S-K.

15-04-2026

At EQT Corporation's Annual Meeting of Shareholders on April 14, 2026, all ten director nominees were elected with strong support, ranging from approximately 88% to 97% of votes cast (For votes between 450,207,215 and 498,018,181 shares). Shareholders also approved the Third Amendment to the 2020 Long-Term Incentive Plan, increasing authorized shares by 34,000,000, a non-binding say-on-pay resolution for 2025 (485,915,092 For), and ratification of Ernst & Young LLP as independent auditors for 2026 (513,890,206 For). All four proposals passed overwhelmingly, with broker non-votes at 37,393,505 shares for most items.

• ·Hallie A. Vanderhider received the lowest director support with 450,207,215 For, 63,277,105 Against, and 1,056,874 Abstained.
• ·Proposal 2 (Say-on-Pay) had 485,915,092 For, 27,460,142 Against, 1,165,960 Abstained.
• ·Proposal 4 (Auditor Ratification) had 513,890,206 For, 37,546,179 Against, 498,314 Abstained.

15-04-2026

Luke Kissam resigned from the Board of Directors of DuPont de Nemours, Inc. effective April 14, 2026, to assume the role of Chief Executive Officer at Corteva, Inc. The departure was not due to any disagreement with the Company's operations, policies, or practices. In response, the Board approved a reduction in its size from 11 to 10 members.

• ·Resignation tendered on April 13, 2026
• ·Date of Report (earliest event): April 13, 2026
• ·Filing date: April 15, 2026

15-04-2026

Marchex, Inc. entered into a Settlement Agreement on April 14, 2026, resolving the civil action Chris Barnard and Sinc McEvenue v. Marchex, Inc. (C.A. No. 1:22-cv-01382-RGA) in the U.S. District Court for the District of Delaware, for the expected settlement amount previously accrued in its 2025 Form 10-K. Pursuant to the agreement, the company will pay $750,000 (and release $250,000 held in escrow by U.S. Bank) on or before May 14, 2026, followed by $500,000 payments on November 16, 2026, and May 17, 2027.

• ·Settlement resolves all claims in the matter; full agreement text to be filed as an exhibit in next periodic report or registration statement.
• ·Further details in Note 10 to Consolidated Financial Statements and Item 3. Legal Proceedings of the 2025 Form 10-K.

15-04-2026

NextDecade Corporation entered into an amended and restated employment agreement with Matthew Schatzman, its Chairman and Chief Executive Officer, effective April 15, 2026, superseding his prior 2017 agreement. The agreement provides for an annual base salary of $1,000,000, a target annual bonus of 130% of base salary, eligibility for long-term incentives, and standard benefits. Severance includes 24 months of base salary plus 200% of target bonus upon termination without cause or for good reason, enhanced to 36 months base plus 300% target bonus if within 24 months post-change of control, with accelerated equity vesting.

• ·Initial term through April 15, 2029, with automatic one-year renewals unless 90 days' notice of non-renewal.
• ·Severance contingent on execution of release of claims.
• ·Includes customary non-competition, non-solicitation covenants, and confidentiality obligations.

15-04-2026

Empire State Realty OP, L.P. (the 'Company') and Empire State Realty Trust, Inc. (the 'Parent') entered into a Note Purchase Agreement dated April 15, 2026, for the issuance and sale of $130,000,000 aggregate principal amount of 5.99% Series M Senior Notes due July 15, 2032. The closing is scheduled for July 15, 2026, at the offices of Morgan, Lewis & Bockius LLP in New York, subject to customary conditions including representations, warranties, and no material adverse effect. No period-over-period financial comparisons or performance metrics are provided in the filing.

• ·Closing to occur not later than 1:00 p.m. New York time on July 15, 2026, or such later business day as mutually agreed.
• ·Notes to be purchased at 100% of principal amount; minimum denominations of $100,000.
• ·No transactions prohibited by Section 10 covenants since December 31, 2025, as a condition to closing.

15-04-2026

Limoneira Company announced the completion of definitive agreements for a 50%/50% joint venture with Agromin to develop a 70-acre commercial composting center on its Santa Paula property, expanding from an existing 15-acre operation to process approximately 295,000 tons of organic waste annually, with operations expected in the second half of fiscal year 2027. The facility will generate revenue from gate fees and compost sales, sharing significant EBITDA equally between partners, while Limoneira will lease the site for approximately $560,000 annually including 89-acre feet of water. This initiative supports California's Senate Bill 1383 organic waste diversion mandates, positioning the center as the only permitted commercial composting facility in Ventura County, expected to divert 75% of the county's landfilled organic waste.

• ·Joint venture follows letter of intent announced in April 2025.
• ·15 years of planning and permitting required for food waste processing.
• ·Limoneira headquartered in Santa Paula, California, with operations in California, Arizona, and Argentina.
• ·Agromin headquartered in Oxnard, California, and is a U.S. Composting Council Composter of the Year recipient.

15-04-2026

Integra LifeSciences Holdings Corporation amended its $150 million accounts receivable securitization facility (A/R Facility) through Amendment No. 8 to the Receivables Financing Agreement and Amendment No. 1 to the Purchase and Sale Agreement on April 10, 2026. The amendments extend the scheduled termination date to April 10, 2029, and update customary representations, covenants, and concentration limits on receivables. This provides continued liquidity and funding support for the company's operations.

• ·Original A/R Facility entered into on December 18, 2018.
• ·Amendments to be filed as exhibits to Form 10-Q for period ended March 31, 2026.

15-04-2026

American Vanguard Corporation disclosed that directors Scott Baskin, Emer Gunter, and Carmen Tiu de Mino notified the Board on April 10, 2026, of their intention not to stand for re-election at the 2026 annual meeting, facilitating a reduction in Board size from nine to seven members as required by the First Lien Term Loan agreement entered March 13, 2026. These departures were not due to any disputes or disagreements with the Company. The Company plans to appoint one independent director in consultation with lenders led by Centerbridge Partners.

• ·Prior 8-K filed March 19, 2026, disclosed the Credit and Guaranty Agreement.
• ·Board changes required within 90 days following March 13, 2026.

15-04-2026

Marvell Technology, Inc. completed a public offering of $1,000,000,000 aggregate principal amount of its 5.300% Senior Notes due 2036 on April 15, 2026, governed by the Fifth Supplemental Indenture with U.S. Bank Trust Company, National Association. Net proceeds of approximately $993.5 million, after underwriters' discount but before other expenses, will be used for repayment of debt including the Company's 1.650% senior notes due 2026, and general corporate purposes such as working capital, dividends, capital expenditures, stock repurchases, and acquisitions. The notes accrue interest at 5.300% per year, payable semi-annually starting October 15, 2026, and mature on April 15, 2036.

• ·Underwriting Agreement dated April 6, 2026, among the Company and representatives Wells Fargo Securities, LLC, BofA Securities, Inc., J.P. Morgan Securities LLC and Mizuho Securities USA LLC.
• ·Prior to par call date of January 15, 2036, Notes redeemable at greater of discounted value using Treasury Rate plus 15 basis points or 100% principal.
• ·Offered pursuant to shelf registration statement on Form S-3 (No. 333-285742) filed March 12, 2025.

15-04-2026

On April 13, 2026, iShares Staked Ethereum Trust ETF (ETHB) entered into an amended and restated addendum to the Coinbase Custody Custodial Services Agreement, which is attached to the Third Amended and Restated Coinbase Prime Broker Agreement dated May 21, 2024. The addendum is filed as Exhibit 10.1. No financial impacts or performance metrics are disclosed in the filing.

• ·Filing submitted on behalf of iShares Delaware Trust Sponsor LLC, the Sponsor of the Trust.
• ·Schedules and exhibits to Exhibit 10.1 omitted pursuant to Item 601(a)(5) of Regulation S-K; available supplementally to SEC upon request.

15-04-2026

On April 10, 2026, Thomas R. Staab, II, Chief Financial Officer of LENSAR, Inc., notified the company of his intention to resign effective May 8, 2026, to pursue other professional opportunities. The resignation is not due to any disagreement with the company's operations, policies, or practices. LENSAR has commenced a search for a new CFO, with Mr. Staab continuing as principal financial officer through the transition date.

• ·The 8-K was filed on April 15, 2026.

15-04-2026

Ecolab Inc. entered into a Term Credit Agreement dated April 10, 2026, acting as Borrower, with financial institutions as Lenders and Citibank, N.A. as Administrative Agent, Sole Arranger, and Sole Bookrunner. The agreement outlines terms for term loans, including interest rates based on SOFR benchmarks with applicable margins, repayment schedules, covenants, and events of default. No specific commitment amounts, loan sizes, or numerical financial terms are detailed in the provided filing excerpt.

• ·Filing Date: April 15, 2026
• ·SEC Items: 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), 9.01 (Financial Statements and Exhibits)
• ·Interest rate floors: Base Rate not less than 1.00%; Adjusted Daily Simple SOFR and Adjusted Term SOFR not less than zero

15-04-2026

On April 10, 2026, 374Water Inc. (SCWO) appointed Richard H. Davis, an experienced investment banker and former director (2008-2025) and CEO of predecessor PowerVerde Inc., to its Board of Directors effective immediately. Mr. Davis will continue coordinating potential financing opportunities, with any successful transactions expected to exceed $120,000 in aggregate. He will receive standard non-employee director compensation, with no board committee assignments determined yet and no other material arrangements disclosed.

• ·Mr. Davis, age 69, holds a B.S. in economics from Florida State University (1982).
• ·Mr. Davis previously served as Board director from February 2008 to June 10, 2025.
• ·No transactions requiring disclosure under Item 404(a) of Regulation S-K involving Mr. Davis or his immediate family.

15-04-2026

Michael R. Heaton resigned from Hagerty, Inc.'s Board of Directors on April 13, 2026, as the designee of Markel Group Inc. under the Investor Rights Agreement, with no disagreements on company matters. The Board accelerated vesting of 10,230 RSUs granted to Heaton on July 1, 2025, originally scheduled for July 1, 2026. Markel designated Henrik W. Bjørnstad as the new Board member, appointed effective April 14, 2026, to the Talent, Culture, and Compensation Committee and the Nominating and Governance Committee.

• ·Investor Rights Agreement dated August 17, 2021
• ·Mr. Bjørnstad entitled to standard non-employee director compensation per proxy statement filed April 24, 2025
• ·No transactions requiring disclosure under Item 404(a) of Regulation S-K involving Mr. Bjørnstad

15-04-2026

Mitesco, Inc. announced the release of a video highlighting Sportzfolio, its strategic partner platform—a digital marketplace for sports facilities initially focused on pickleball, with plans to expand to soccer, tennis, golf, and basketball. The platform is developed via Vero Technology Ventures and hosted on Mitesco's Centcore Data Center, with a revenue sharing arrangement aligning long-term interests. This milestone supports upcoming pilot programs, sponsorships, and market rollout ahead of MVP launch.

• ·Video available at: https://www.youtube.com/watch?v=x2rDJtDiiLo
• ·Filing Date: April 15, 2026; Announcement Date: April 09, 2026

15-04-2026

Corebridge Financial, Inc. appointed Christopher Filiaggi, its Chief Accounting Officer since June 2023, as Interim Chief Financial Officer effective April 24, 2026, succeeding Elias Habayeb who will depart on the same date, in preparation for the company's planned merger with Equitable Holdings, Inc. Filiaggi will serve until merger close, when Equitable Holdings' CFO Robin M. Raju will assume the role for the combined entity. The company manages $385 billion in assets under management and administration as of December 31, 2025, amid forward-looking statements cautioning on merger risks including regulatory approvals and integration challenges.

• ·Filiaggi previously held finance leadership positions at Corebridge and AIG, and advised insurance clients at PricewaterhouseCoopers LLP on accounting and compliance.
• ·Merger forward-looking risks include regulatory approvals, integration delays, business disruptions, and potential failure to realize synergies.

15-04-2026

On April 15, 2026, PAR Technology Corporation entered into a Board Observer Agreement with Voss Capital entities, appointing Jon Hook as a non-voting observer to the Board of Directors. The observer receives meeting materials and can attend meetings subject to exceptions for confidentiality and conflicts, with the agreement lasting one year and terminable under specified conditions including ownership thresholds. No fees are involved, only potential expense reimbursement for in-person attendance.

• ·Observer has no voting rights or fiduciary duties
• ·Termination triggers include uncured material breach, seeking board representation, or Voss Capital falling below minimum ownership threshold
• ·Agreement includes confidentiality and non-disparagement provisions